Yan et al.[3] reported that more than 70% of WHO grade II and III astrocytomas and oligodendrogliomas had mutations in amino acid position 132 of IDH1. IDH1 mutations also have been shown to occur predominantly in younger patients [5]. The gene discussed is IDH1; the disease is oligodendroglioma.